Return On Equity of GlobeStar Therapeutics Corp from 31 Mar 2012 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
GlobeStar Therapeutics Corp quarterly and annual Return On Equity in % history and change rate from 31 Mar 2012 to 30 Jun 2024.
  • GlobeStar Therapeutics Corp Return On Equity for the quarter ending 30 Jun 2024 was 59%, a 62% decline year-over-year.
  • GlobeStar Therapeutics Corp annual Return On Equity for 2023 was 149%, a 3.6% increase from 2022.
  • GlobeStar Therapeutics Corp annual Return On Equity for 2022 was 144%, a 91% decline from 2021.
  • GlobeStar Therapeutics Corp annual Return On Equity for 2021 was 1615%, a 1765% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

GlobeStar Therapeutics Corp Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 59% -94% -62% 01 Apr 2024 30 Jun 2024
Q1 2024 138% +71% +107% 01 Jan 2024 31 Mar 2024
Q4 2023 141% +23% +19% 01 Oct 2023 31 Dec 2023
Q3 2023 149% +5% +3.6% 01 Jul 2023 30 Sep 2023
Q2 2023 153% -440% -74% 01 Apr 2023 30 Jun 2023
Q1 2023 67% -1109% -94% 01 Jan 2023 31 Mar 2023
Q4 2022 118% -1401% -92% 01 Oct 2022 31 Dec 2022
Q3 2022 144% -1471% -91% 01 Jul 2022 30 Sep 2022
Q2 2022 593% -375% -39% 01 Apr 2022 30 Jun 2022
Q1 2022 1176% +958% +439% 01 Jan 2022 31 Mar 2022
Q4 2021 1519% +1440% +1835% 01 Oct 2021 31 Dec 2021
Q3 2021 1615% +1528% +1765% 01 Jul 2021 30 Sep 2021
Q2 2021 968% +885% +1069% 01 Apr 2021 30 Jun 2021
Q1 2021 218% +152% +229% 01 Jan 2021 31 Mar 2021
Q4 2020 78% +8% +11% 01 Oct 2020 31 Dec 2020
Q3 2020 87% 0% -0.56% 01 Jul 2020 30 Sep 2020
Q2 2020 83% -7% -8% 01 Apr 2020 30 Jun 2020
Q1 2020 66% -34% -34% 01 Jan 2020 31 Mar 2020
Q4 2019 71% -12% -15% 01 Oct 2019 31 Dec 2019
Q3 2019 87% -16% -15% 01 Jul 2019 30 Sep 2019
Q2 2019 90% -126% -58% 01 Apr 2019 30 Jun 2019
Q1 2019 100% -106% -52% 01 Jan 2019 31 Mar 2019
Q4 2018 83% -130% -61% 01 Oct 2018 31 Dec 2018
Q3 2018 103% -86% -45% 01 Jul 2018 30 Sep 2018
Q2 2018 216% 01 Apr 2018 30 Jun 2018
Q1 2018 206% 01 Jan 2018 31 Mar 2018
Q4 2017 213% 01 Oct 2017 31 Dec 2017
Q3 2017 189% 01 Jul 2017 30 Sep 2017
Q2 2016 -141% -803% -121% 30 Apr 2016 30 Jun 2016
Q1 2016 761% -304% -29% 01 Jan 2016 31 Mar 2016
Q4 2015 976% +25% +2.6% 01 Oct 2015 31 Dec 2015
Q3 2015 880% -422% -32% 01 Jul 2015 30 Sep 2015
Q2 2015 663% -17207% -96% 01 Apr 2015 30 Jun 2015
Q1 2015 1065% +4706% 01 Jan 2015 31 Mar 2015
Q4 2014 951% +2518% 01 Oct 2014 31 Dec 2014
Q3 2014 1302% +3391% 01 Jul 2014 30 Sep 2014
Q2 2014 17870% +16167% +949% 01 Apr 2014 30 Jun 2014
Q1 2014 -3641% -4624% -470% 01 Jan 2014 31 Mar 2014
Q4 2013 -1567% -2193% -350% 01 Oct 2013 31 Dec 2013
Q3 2013 -2089% -2789% -399% 01 Jul 2013 30 Sep 2013
Q2 2013 1703% +1014% +147% 01 Apr 2013 30 Jun 2013
Q1 2013 983% +624% +174% 01 Jan 2013 31 Mar 2013
Q4 2012 626% 01 Oct 2012 31 Dec 2012
Q3 2012 699% 01 Jul 2012 30 Sep 2012
Q2 2012 689% 01 Apr 2012 30 Jun 2012
Q1 2012 359% 01 Jan 2012 31 Mar 2012

GlobeStar Therapeutics Corp Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 149% +5% +3.6% 01 Oct 2022 30 Sep 2023
2022 144% -1471% -91% 01 Oct 2021 30 Sep 2022
2021 1615% +1528% +1765% 01 Oct 2020 30 Sep 2021
2020 87% 0% -0.56% 01 Oct 2019 30 Sep 2020
2019 87% -16% -15% 01 Oct 2018 30 Sep 2019
2018 103% -86% -45% 01 Oct 2017 30 Sep 2018
2017 189% 01 Oct 2016 30 Sep 2017
2015 880% -422% -32% 01 Oct 2014 30 Sep 2015
2014 1302% +3391% 01 Oct 2013 30 Sep 2014
2013 -2089% -2789% -399% 01 Oct 2012 30 Sep 2013
2012 699% 01 Oct 2011 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.